Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 02.11.2026 1 Anesthesiol Res Pract 1 Anticancer Res 1 Asian Pac J Cancer Prev 1 Bioengineering (Basel) 1 Bioinformatics 1 Biotech Histochem 1 BMB Rep 1 BMC Bioinformatics 1 BMC Public Health 4 BMC Womens Health 1 Brachytherapy 1 Cancer Nurs 1 Cancer Sci 1 Cancers (Basel) 1 Cell Mol Life Sci 1 Chem Mater 1 Commun Biol 1 Cureus 1 Curr Oncol 1 Diagnostics (Basel) 1 Eur J Cancer 1 Front Cell Dev Biol 1 Front Digit Health 1 Front Immunol 1 Front Med (Lausanne) 2 Front Oncol 2 Front Public Health 1 Glob Health Med 2 Gynecol Oncol 1 Gynecol Oncol Rep 1 Health Expect 1 Healthcare (Basel) 1 Hereditas 1 In Vivo 2 Indian J Pathol Microbiol 1 Int J Clin Oncol 1 Int J Gynaecol Obstet 2 Int J Gynecol Cancer 2 Int J Mol Sci 1 Int J Nanomedicine 1 Int J Public Health 1 Int J Radiat Oncol Biol Phys 1 Int J Surg Pathol 1 Intervirology 1 iScience 1 J Assoc Nurses AIDS Care 1 J Cancer Res Clin Oncol 2 J Cancer Res Ther 1 J Chemother 1 J Clin Med 1 J Eval Clin Pract 8 J Gynecol Obstet Hum Reprod 2 J Gynecol Oncol 1 J Infect Chemother 1 J Low Genit Tract Dis 1 J Med Screen 1 J Med Virol 2 J Obstet Gynaecol Can 1 J Relig Health 1 J Transl Med 1 Lab Med 1 Lancet HIV 1 Math Biosci 1 Med Sci (Basel) 1 Microorganisms 2 Mol Biol Rep 1 Mol Cell Biochem 1 Molecules 1 NEJM AI 1 Oncologist 1 Pak J Pharm Sci 2 PLoS One 1 Polymers (Basel) 1 Prep Biochem Biotechnol 1 Psychooncology 1 Rev Bras Ginecol Obstet 2 Surg Pathol Clin 2 Taiwan J Obstet Gynecol 1 Virchows Arch 1 Virus Res 1 Zhong Nan Da Xue Xue Bao Yi Xue Ban

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anesthesiol Res Pract

1. ZHANG Z, Dong X, Yu T, Li H, et al
   VAMP5 Mediates Sevoflurane-Induced Immune Modulation in Cervical Cancer: A Clinical Translational Study.
   Anesthesiol Res Pract. 2026;2026:9114246.
   PubMed         Abstract available
   
   

   
   Anticancer Res

2. UTSUMI N, Kawamura H, Yamano T, Hayakawa T, et al
   Retrospective Study of Pelvic Irradiation in Patients With Advanced Uterine Cervical Cancer.
   Anticancer Res. 2026;46:6175-6182.
   PubMed         Abstract available
   
   

   
   Asian Pac J Cancer Prev

3. OHAKA N, Okere GN, Asuzu NC, Ekenedo GO, et al
   Institutional and Demographic Barriers to Cervical Cancer Screening among Women in Rivers State, Nigeria.
   Asian Pac J Cancer Prev. 2026;27:3809-3815.
   PubMed         Abstract available
   
   

   
   Bioengineering (Basel)

4. CHANG H, Wang X, Wu Y, Li Q, et al
   Engineering Polymeric Biomaterials for Radiation-Induced Vaginal Injury After Cervical Cancer Therapy: Pathobiological Basis, Material Strategies, and Future Perspectives.
   Bioengineering (Basel). 2026;13:1169.
   PubMed         Abstract available
   
   

   
   Bioinformatics

5. ZHOU L, Cai Q, Wang X, Li W, et al
   FMCerNet: frequency-aware multi-label learning for fine-grained cervical cytology screening.
   Bioinformatics. 2026;42:btag759.
   PubMed         Abstract available
   
   

   
   Biotech Histochem

6. CAJAS-SALAZAR N, Mueses-Moreno LJ, Sierra-Torres CH
   Micronucleus cytome assay reveals genomic instability in premalignant cervical lesions among high-risk HPV-positive women.
   Biotech Histochem. 2026;101:501-512.
   PubMed         Abstract available
   
   

   
   BMB Rep

7. KUMAR N, Kumar RR, Singh A, Vyas A, et al
   Silencing of E6/E7 proteins of HPV-16 in the CaCx cell line upregulate the expression of POTE-Paralogs.
   BMB Rep. 2026;59:466-473.
   PubMed         Abstract available
   
   

   
   BMC Bioinformatics

8. DENG Z, Bi X, Zhang H
   A knowledge graph-guided transcriptomic framework identifies a 20-gene prognostic signature for cervical cancer.
   BMC Bioinformatics. 2026;27:248.
   PubMed         Abstract available
   
   

   
   BMC Public Health

9. LEGENDRE E, Dutrey-Kaiser A, Attalah Y, Boyer G, et al
   Effectiveness of health mediation to promote organised cancer screening among underserved and under-screened populations in Marseille, France: findings from a repeated cross-sectional survey.
   BMC Public Health. 2026;26:3129.
   PubMed         Abstract available
   
   

   
   BMC Womens Health

10. BIARI H, Galeshi M, Yazdani S, Ranaei M, et al
    Cervical cytological abnormalities and human papillomavirus status in HPV-vaccinated and unvaccinated women: a cross-sectional study.
    BMC Womens Health. 2026;26:572.
    PubMed         Abstract available
    
    
11. ALI ZM, Boutib A, Said KS, Saad ELM, et al
    Health-related quality of life among Djiboutian women with gynecological cancers, predominantly cervical cancer : a cross-sectional analytical study.
    BMC Womens Health. 2026;26:561.
    PubMed         Abstract available
    
    
12. HE J, Wang D, Fu M, Wu Y, et al
    Immediate histological risk and one-year outcomes following P16-based triage of HPV-positive women.
    BMC Womens Health. 2026;26:559.
    PubMed         Abstract available
    
    
13. GASHU C, Tasfa B, Alemu C, Kassa Y, et al
    Retraction Note: Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach.
    BMC Womens Health. 2026;26:553.
    PubMed        
    
    

    
    Brachytherapy

14. PORTOCARRERO-BONIFAZ A, Parisi A, Viviers E, McLemore LB, et al
    EQD2 In modern cervix HDR brachytherapy: Clinical utility, sources of uncertainty, and interpretation.
    Brachytherapy. 2026;25:981-991.
    PubMed         Abstract available
    
    

    
    Cancer Nurs

15. AROH AC, Madujibeya I, Asante Antwi H, Aroh U, et al
    Examining the Role of Social Determinants of Health on Adherence to Pap Screening Guidelines for US Women Aged 21 to 64 Years: Evidence From the 2022 Health Information National Trends Survey.
    Cancer Nurs. 2026;49:e859-e867.
    PubMed         Abstract available
    
    

    
    Cancer Sci

16. LIU Y, Xi H, Min S, Yang H, et al
    Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis.
    Cancer Sci. 2026 Oct 23:10.1111/cas.70560. doi: 10.1111/cas.70560.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

17. FAN Y, Lian CW, Yang XY, Li JK, et al
    Comparison of Survival After Radical Hysterectomy or Radical Radiotherapy Among Patients with Different Histological Types of Locally Advanced Cervical Cancer: Analysis of SEER Data Using Propensity Score Matching.
    Cancers (Basel). 2026;18:3371.
    PubMed         Abstract available
    
    

    
    Cell Mol Life Sci

18. MAI Y, Hua H, Liang S, Ye G, et al
    Ubiquitination of parkin influences its tumor suppressive function in cervical cancer.
    Cell Mol Life Sci. 2026;83:395.
    PubMed         Abstract available
    
    

    
    Chem Mater

19. CASTRIGNANO E, Sarcina L, Mongelli V, Iacobellis I, et al
    Biofunctional Molecular Large Surfaces Enabling Ultrasensitive Detection for Early Diagnosis of Cervical Cancer.
    Chem Mater. 2026;38:10515-10524.
    PubMed         Abstract available
    
    

    
    Commun Biol

20. MOLINA MA, Zhang Y, Steenbergen RDM, Melchers WJG, et al
    Towards a sequential microbiome therapy for HPV-associated cervicovaginal dysbiosis.
    Commun Biol. 2026;9:1422.
    PubMed         Abstract available
    
    

    
    Cureus

21. KOSHY E, Son C
    Population-Level Shifts in Cervical Cancer Stage Distribution in the United States Following Human Papillomavirus (HPV) Vaccine Implementation.
    Cureus. 2026;18:e118618.
    PubMed         Abstract available
    
    

    
    Curr Oncol

22. CHEN J, Jiang F, Chen X, Lin R, et al
    MRI-Based Radiomics Model for Pretreatment Prediction of Pathological Lymph Node Metastasis in Neuroendocrine Carcinoma of the Cervix: Dual-Center Development and External Validation.
    Curr Oncol. 2026;33:625.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

23. KATOH Y, Fujii Y, Yamazaki N, Kubo A, et al
    Serum Free Fatty Acid-Based Diagnostic Index for Cervical Cancer Including High-Risk HPV-Negative Cases: An Independent Validation Study.
    Diagnostics (Basel). 2026;16:3387.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

24. ELLIS LB, Bowden SJ, Tighe J, Arbyn M, et al
    Response to letter Re: Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2026;249:117779.
    PubMed        
    
    

    
    Front Cell Dev Biol

25. JIANG J, Zhang Y, Wang M, Zhang R, et al
    Exploratory transcriptomic profiling of melittin's efficacy in the treatment of murine cervical cancer cells.
    Front Cell Dev Biol. 2026;14:1975665.
    PubMed         Abstract available
    
    

    
    Front Digit Health

26. HARERIMANA A, Mchunu G
    Text, talk, screen: mapping mHealth interventions for cervical cancer prevention and control in Africa - a scoping review.
    Front Digit Health. 2026;8:1947988.
    PubMed         Abstract available
    
    

    
    Front Immunol

27. RESENDIZ-CASTILLO LJ, Martinez-Barajas MG, Carranza-Aranda AS, Garcia-Bernal JR, et al
    Cancer-associated fibroblasts from cervical cancer modulate protumoral neutrophil functions: evidence from a pilot exploratory study.
    Front Immunol. 2026;17:1900567.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

28. GONG W, Liu X, Wang M, Hu X, et al
    Multi-sequence magnetic resonance imaging radiomics integrated with clinical features predicts pelvic lymph node metastasis in cervical cancer: a retrospective-prospective cohort study.
    Front Med (Lausanne). 2026;13:1910248.
    PubMed         Abstract available
    
    

    
    Front Oncol

29. YUE W, Tian H, Cai X, Yu B, et al
    IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.
    Front Oncol. 2026;16:1885498.
    PubMed         Abstract available
    
    
30. 
    Correction: Trends in cervical cancer incidence and mortality in Mongolia, 2014-2024: a population-based analysis of pandemic-related disruptions.
    Front Oncol. 2026;16:1993185.
    PubMed         Abstract available
    
    

    
    Front Public Health

31. SEFUTHI T, Van Schalkwyk C, Nkonki L
    A patient costing analysis of Lesotho's cervical cancer screening program.
    Front Public Health. 2026;14:1888325.
    PubMed         Abstract available
    
    
32. LI H, Ke Y, Wu M, Shen L, et al
    Cervical cancer screening willingness and associated health beliefs among predominantly college-educated young women attending gynecology clinics in Shenzhen, China.
    Front Public Health. 2026;14:1969898.
    PubMed         Abstract available
    
    

    
    Glob Health Med

33. CHEPKOECH P, Jordan SB, Makhulo B, Ambaka J, et al
    Assessing an educational strategy to improve community health provider-led provision of cervical cancer screening services in western Kenya: A secondary analysis of the Elimisha-HPV cluster-randomized controlled trial.
    Glob Health Med. 2026;8:332-341.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

34. RIESE C, Yi-Tung Chen E, Nilsson H, Salehi S, et al
    Corrigendum to "Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old)". [Gynecol. Oncol. 212 (2026) 152-159].
    Gynecol Oncol. 2026;215:41.
    PubMed        
    
    
35. HOLT HK, Ma W, Gordon HS, Sun J, et al
    Trends in utilization of cervical cancer screening and screening-associated services in a multi-organizational research network in Chicago, Illinois, US.
    Gynecol Oncol. 2026;214:173-181.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

36. CHAVANA A, Flanagan M, Owrangi A, Sharma S, et al
    Real-world experience with INTERLACE-style induction chemotherapy: Tumor regression and MRI-guided brachytherapy in locally advanced cervical cancer.
    Gynecol Oncol Rep. 2026;68:102231.
    PubMed         Abstract available
    
    

    
    Health Expect

37. WINKLER L, Power R, Allison KR, Strnadova I, et al
    The Role of Self-Collection in Optimising Cervical Screening for People With Intellectual Disability: A Multi Perspective Qualitative Study.
    Health Expect. 2026;29:e70920.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

38. LOPEZ-GONZALEZ DB, Sertic M, Moskowitz CS, Rasmussen RG, et al
    Uterine Cervical Cancer Treatment and Outcomes Among Medicare-Insured Patients in the United States.
    Healthcare (Basel). 2026;14:3488.
    PubMed         Abstract available
    
    

    
    Hereditas

39. YIN K, Li Y, Tang M
    LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/beta-catenin pathway in cervical cancer.
    Hereditas. 2026;163:120.
    PubMed         Abstract available
    
    

    
    In Vivo

40. MATSUMOTO T, Yoshida K, Nakai M, Kawamura Y, et al
    Incidence of Nausea and Vomiting in Patients With Cervical Cancer Undergoing Chemoradiotherapy With Steroid-Sparing.
    In Vivo. 2026;40:3763-3774.
    PubMed         Abstract available
    
    

    
    Indian J Pathol Microbiol

41. RANA S, Kundu A, Ghosh D, Datta P, et al
    Comparative immunohistochemical analysis of survivin, p53, and Ki-67 expression in cervical squamous intraepithelial lesions and squamous cell carcinoma.
    Indian J Pathol Microbiol. 2026;69:419-424.
    PubMed         Abstract available
    
    
42. VERMA RS, Asmita A, Singh V, Kumari R, et al
    Diagnostic and prognostic significance of p16, p53, and PD-L1 expression in cervical lesions: A combined immunohistochemical, histopathological, and radiological correlation study.
    Indian J Pathol Microbiol. 2026;69:413-418.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

43. YOKOI A, Machida H, Okazawa-Sakai M, Nishino K, et al
    Correction: Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.
    Int J Clin Oncol. 2026 Oct 29. doi: 10.1007/s10147-026-03225.
    PubMed        
    
    

    
    Int J Gynaecol Obstet

44. SNYMAN LC, Visser C, Dreyer GJ, Lukhwareni A, et al
    Comparison of self-sampling versus clinician-sampling HPV DNA cervical cancer screening in South African women living with and without HIV.
    Int J Gynaecol Obstet. 2026 Oct 29. doi: 10.1002/ijgo.71469.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

45. MELLO GRAZIANO L, Nogueira-Rodrigues A
    Building a common language for cervical cancer clinical trials.
    Int J Gynecol Cancer. 2026 Aug 22:104991. doi: 10.1016/j.ijgc.2026.104991.
    PubMed        
    
    
46. CARUSO G, Casaccia Giordano F, Zanagnolo V, Aloisi A, et al
    International expert consensus on the contemporary role of pelvic exenteration in recurrent or persistent cervical cancer.
    Int J Gynecol Cancer. 2026;36:105629.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

47. DWORNIK R, Cylwik D, Bialkowska K
    Immune Response Gene Polymorphisms and Cervical Cancer Susceptibility.
    Int J Mol Sci. 2026;27:9384.
    PubMed         Abstract available
    
    
48. KORNIENKO TE, Zakharenko AL, Chernyshova IA, Chepanova AA, et al
    Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan.
    Int J Mol Sci. 2026;27:9266.
    PubMed         Abstract available
    
    

    
    Int J Nanomedicine

49. HUANG L, Hu Y, Yu Y
    Ultrasound-Responsive Nanoplatforms in HPV-Associated Cervical Cancer: Reprogramming the Post-Infection Microenvironment.
    Int J Nanomedicine. 2026;21:642841.
    PubMed         Abstract available
    
    

    
    Int J Public Health

50. CARMACK C, Ahmed N, Marinoni A, Ousley T, et al
    Feasibility and proof-of-concept of a cervical cancer prevention edutainment webisode for African American women in Houston, Texas.
    Int J Public Health. 2026;71:1609804.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

51. HANDE V, Ndarukwa S, Rubio AP, Berger D, et al
    Implementing Image-Guided Brachytherapy (IGBT) For Cervical Cancer in Resource-Limited Settings: An International Multicentric Cross-Sectional Study of Resource and Workflow Impact.
    Int J Radiat Oncol Biol Phys. 2026 Oct 30:S0360-3016(26)04396.
    PubMed         Abstract available
    
    

    
    Int J Surg Pathol

52. ZHANG K
    Mesonephric-like Adenocarcinoma of the Female Genital Tract: A Comprehensive Review of Clinicopathological, Immunophenotypic, Molecular Features, and Clinical Management.
    Int J Surg Pathol. 2026;34:1945-1957.
    PubMed         Abstract available
    
    

    
    Intervirology

53. TAGAJDID MR, Azelmat S, Goura H, Znady MR, et al
    Human Papillomavirus Genotype Distribution among Adult Women in the Rabat Region (Morocco): A Retrospective and Analytical Study with Implications for HPV Vaccination Strategies.
    Intervirology. 2026;69:34-43.
    PubMed         Abstract available
    
    

    
    iScience

54. LIU J, Wang J, Gao Y, Cui X, et al
    ELAVL1 overexpression potentiates cervical cancer malignancy via regulating the ACVRL1/CASP14 pathway.
    iScience. 2026;29:117956.
    PubMed         Abstract available
    
    

    
    J Assoc Nurses AIDS Care

55. BERGMAN AJ, Daniels-Donkor S, Go S, Datesman AR, et al
    HIV and Human Papilloma Virus Community Service Integration Among Women: A Systematic Review and Narrative Synthesis.
    J Assoc Nurses AIDS Care. 2026;37:e70-e82.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

56. FANG C, Liu S, Xia J, Wu X, et al
    Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial.
    J Cancer Res Clin Oncol. 2026;152:204.
    PubMed         Abstract available
    
    

    
    J Cancer Res Ther

57. MAJHI S, Saini R, Kumar R, Sharma DN, et al
    Synchronous presacral schwannoma and carcinoma cervix: A rare diagnostic and therapeutic dilemma.
    J Cancer Res Ther. 2026;22:1011-1015.
    PubMed         Abstract available
    
    
58. BAJWA HK, Natte R, Beriwal S, Chaudhari S, et al
    Outcomes of MR interstitial hybrid brachytherapy in Carcinoma Cervix with novel commercial intravaginal template - initial results from an Indian cancer center.
    J Cancer Res Ther. 2026;22:987-992.
    PubMed         Abstract available
    
    

    
    J Chemother

59. FATIMA E, Abdul Rehman K, Ur Rehman O, Salih N, et al
    Efficacy and safety of adjuvant chemotherapy for locally advanced cervical carcinoma: an updated Systematic review and meta-analysis.
    J Chemother. 2026;38:603-618.
    PubMed         Abstract available
    
    

    
    J Clin Med

60. ATES S, Ay A, Coker GB, Gjergjizi N, et al
    Real-World Guideline Concordance and Potential Overtreatment Following Primary Radical Hysterectomy for Early-Stage Cervical Cancer.
    J Clin Med. 2026;15:7952.
    PubMed         Abstract available
    
    

    
    J Eval Clin Pract

61. LIAO X, Liu Y, Tang Y, Lei Y, et al
    Quality Disparities and Recommendation Consistency of Cervical Cancer Screening Guidelines: A Systematic Appraisal With the AGREE II Instrument.
    J Eval Clin Pract. 2026;32:e70703.
    PubMed         Abstract available
    
    

    
    J Gynecol Obstet Hum Reprod

62. MIMOUN C, Carcopino X, Carcopino X, Ouldamer L, et al
    ASSESSMENT OF TREATMENT RESPONSE RESPONSE AND THE ROLE OF COMPLETION SURGERY AFTER CONCURRENT CRTAND BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 30:103311.
    PubMed         Abstract available
    
    
63. CARCOPINO X, Ouldamer L, Huchon C, Leveque J, et al
    FROM EVIDENCE REVIEW TO CLINICAL RECOMMENDATIONS: FRENCH GUIDELINES FOR CERVICAL CANCER MANAGEMENT FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 29:103318.
    PubMed        
    
    
64. DUGAST M, Moureau A, Tromelin E, Sousa C, et al
    CERVICAL CANCER IN OLDER WOMEN - A NARRATIVE REVIEW OF AGE-SPECIFIC MANAGEMENT ISSUES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 29:103317.
    PubMed         Abstract available
    
    
65. BUFFETEAU A, Chauvet P, Cordoba A, Leveque J, et al
    POST-TREATMENT SURVEILLANCE AND MANAGEMENT OF RECURRENT CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 29:103315.
    PubMed         Abstract available
    
    
66. CARCOPINO X, Ouldamer L, Huchon C, Asseeva P, et al
    CERVICAL CANCER: NATIONAL CLINICAL PRACTICE GUIDELINES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103314.
    PubMed         Abstract available
    
    
67. OULDAMER L, Deberti M, Morineau F, Carcopino X, et al
    Risk-Adapted surgical treatment of early-stage cervical cancer: tailoring radicality, ovarian preservation, and surgical approach in the post-shape and post-lacc era - A review from the french cervical cancer guidelines group.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103316.
    PubMed         Abstract available
    
    
68. FUSS E, Lecointre L, Gladieff L, Bendifallah S, et al
    Special situations in cervical cancer management: de novo metastatic disease, occult cancer after simple hysterectomy, and cervical stump cancer - A review from the french cervical cancer guidelines group.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103312.
    PubMed         Abstract available
    
    
69. MARGUERITTE F, Mathevet P, Diguisto C, Carcopino X, et al
    FERTILITY-SPARING SURGERY AND OVARIAN TRANSPOSITION IN CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103313.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

70. WANG S, Ding J, Chen X, Zhao M, et al
    Non-cancer causes of death following cervical cancer diagnosis: a SEER database study.
    J Gynecol Oncol. 2026 Oct 19. doi: 10.3802/jgo.2027.
    PubMed         Abstract available
    
    
71. WANG W, Lin Z, Liu J
    Radical versus simple trachelectomy for fertility preservation in early-stage cervical cancer: a retrospective cohort study based on propensity score inverse probability of treatment weighting.
    J Gynecol Oncol. 2026 Oct 16. doi: 10.3802/jgo.2027.
    PubMed         Abstract available
    
    

    
    J Infect Chemother

72. MAKITA C, Yin L, Kobayashi S, Kajiura Y, et al
    Listeria monocytogenes meningitis after pembrolizumab-based chemoradiotherapy for cervical cancer: A case report.
    J Infect Chemother. 2026;32:103114.
    PubMed         Abstract available
    
    

    
    J Low Genit Tract Dis

73. WANG B, Chang Z
    Effect of Solution-focused Outpatient Follow-up on Post-surgery Resilience and Sexual QoL in Cervical Cancer.
    J Low Genit Tract Dis. 2026 Oct 28. doi: 10.1097/LGT.0000000000000988.
    PubMed         Abstract available
    
    

    
    J Med Screen

74. VERA-PONCE VJ, Ballena-Caicedo J, Garcia-Rodriguez M, Sagastegui Jauregui JD, et al
    Scaling up primary HPV DNA screening and self-sampling for cervical cancer in Peru: Coverage, cost-utility, and budget impact analysis using public data sources.
    J Med Screen. 2026 Oct 29:9691413261494992. doi: 10.1177/09691413261494992.
    PubMed         Abstract available
    
    

    
    J Med Virol

75. SCHICHL K, Doorbar J
    Productive or Transforming? How Epithelial Compartmentalization of HPV DNA and E6/E7 Transcripts Shapes Cervical Screening Assay Performance.
    J Med Virol. 2026;98:e71196.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Can

76. GRAY K, McRae K, Kong I, Altas M, et al
    Hormone replacement after radiotherapy for premenopausal patients with cervical cancer: a retrospective cohort study.
    J Obstet Gynaecol Can. 2026 Oct 30:103559. doi: 10.1016/j.jogc.2026.103559.
    PubMed         Abstract available
    
    
77. BAKHACHE N, Winkler E, Castelo M, Selk A, et al
    Exploring the Differences in Severity of Cervical Dysplasia between Ontario Residents and Refugees: A Retrospective Cohort Study.
    J Obstet Gynaecol Can. 2026;48:103500.
    PubMed         Abstract available
    
    

    
    J Relig Health

78. OZCAN E
    The Relationship Between Attitudes Toward Early Detection of Cervical Cancer, Religious Health Fatalism, and Hope levels in Women: A Cross-Sectional Study in Turkiye.
    J Relig Health. 2026 Oct 28. doi: 10.1007/s10943-026-02817.
    PubMed         Abstract available
    
    

    
    J Transl Med

79. WANG H, Li Y, Zheng J, Wang J, et al
    BRAP maintains SEC24D stability to regulate ER stress and promote cervical adenocarcinoma progression.
    J Transl Med. 2026;24:1331.
    PubMed         Abstract available
    
    

    
    Lab Med

80. LIU N, Niu S, Sun X, Xin H, et al
    Dysregulation of the miR-557/MELK axis and its correlation with tumor markers in cervical cancer.
    Lab Med. 2026;57:lmag085.
    PubMed         Abstract available
    
    

    
    Lancet HIV

81. MCCLYMONT E, Blitz S, Nicolls S, Lee M, et al
    Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study.
    Lancet HIV. 2026;13:e779-e787.
    PubMed         Abstract available
    
    

    
    Math Biosci

82. MIDHUN TA, Murugesan K
    Vaccination-driven suppression, stochastic variability, and contact saturation in HPV-cervical cancer transmission in India: A Black-Karasinski perturbation model.
    Math Biosci. 2026 Oct 27:109839. doi: 10.1016/j.mbs.2026.109839.
    PubMed         Abstract available
    
    

    
    Med Sci (Basel)

83. SCRIPCARIU IS, Matasariu DR, Socolov DG, Anton GI, et al
    Anxiety and Depression in Cervical Cancer Patients in Relation to Nutritional Status and Oxidative Stress.
    Med Sci (Basel). 2026;14:657.
    PubMed         Abstract available
    
    

    
    Microorganisms

84. ZHOU X, Hu J, Zhou R, Lu Y, et al
    The Vaginal Microbiome Across the Continuum from HPV Infection to Cervical Cancer: A Narrative Review.
    Microorganisms. 2026;14:2158.
    PubMed         Abstract available
    
    

    
    Mol Biol Rep

85. GOODARZI M, Aghbash PS, Baghi HB
    HPV-associated extracellular vesicles and the tumor microenvironment: mechanisms of immune modulation and translational implications.
    Mol Biol Rep. 2026;53:1857.
    PubMed         Abstract available
    
    
86. MO X, Wang H, Wang Z, Xiao Y, et al
    Multifaceted HPV16 E2 as a potential therapeutic target for cervical cancer and beyond.
    Mol Biol Rep. 2026;53:1858.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

87. MAITY G, Fahreen S, Banerji A, Choudhury PR, et al
    Correction to: Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa).
    Mol Cell Biochem. 2026 Oct 30. doi: 10.1007/s11010-026-05769.
    PubMed        
    
    

    
    Molecules

88. MERECZ-SADOWSKA A, Kowalski M, Kowalczyk T, Trzcinski M, et al
    Celastrol and Its Derivatives in Breast, Ovarian, and Cervical Cancer: Molecular Targets, Signalling Networks, and Nanocarrier-Based Delivery.
    Molecules. 2026;31:3641.
    PubMed         Abstract available
    
    

    
    NEJM AI

89. LAHRMANN B, Keil A, Miranda Ruiz F, Clarke MA, et al
    Closing the Automation Gap in HPV-Based Cervical Cancer Screening: Independent External Validation of an AI Model for Dual-Stain Triage.
    NEJM AI. 2026;3:AIoa2600270.
    PubMed         Abstract available
    
    

    
    Oncologist

90. SAAD A, Goldstein J, Atamneh R, Helpman L, et al
    Pelvic Insufficiency Fractures After Chemoradiotherapy for Cervical Cancer: Incidence, Long-Term Outcomes, and Survivorship Management.
    Oncologist. 2026 Oct 23:oyag427. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Pak J Pharm Sci

91. MA N, Xu K, Wang Z
    Study on the molecular mechanism of bone marrow mesenchymal stem cells inducing epithelial-mesenchymal transition in HPV-associated cervical cancer through activation of miR-129.
    Pak J Pharm Sci. 2027;40:326-341.
    PubMed         Abstract available
    
    

    
    PLoS One

92. LANGHE R, AlKhatib A, Saber A, Saqr D, et al
    Cultural and structural barriers to HPV vaccine acceptance among young women in the United Arab Emirates.
    PLoS One. 2026;21:e0346507.
    PubMed         Abstract available
    
    
93. BLYTHE R, Graves N, Iyer NG, Peres MA, et al
    Age-specific income losses due to HPV-attributable cancers in Singapore.
    PLoS One. 2026;21:e0361921.
    PubMed         Abstract available
    
    

    
    Polymers (Basel)

94. WANG X, Lin N, Cao Y, Vishwakarma J, et al
    Polymer-Based Additive Manufacturing in Cervical Cancer Management: A Review.
    Polymers (Basel). 2026;18:2455.
    PubMed         Abstract available
    
    

    
    Prep Biochem Biotechnol

95. T SF, M R, Packirisamy V, Gopinath SCB, et al
    Gold-molybdenum disulfide functional nanocomposites for cervical cancer therapy: in vitro anticancer activity and modulation of pro-apoptotic markers.
    Prep Biochem Biotechnol. 2026 Oct 29:1-9. doi: 10.1080/10826068.2026.2749457.
    PubMed         Abstract available
    
    

    
    Psychooncology

96. MCNAIR A, Dau H, Nakisige C, Smith L, et al
    Exploring the Social and Financial Impacts of Cervical Cancer on Caregivers in Low- and Middle-Income Countries: A Scoping Review.
    Psychooncology. 2026;35:e70641.
    PubMed         Abstract available
    
    

    
    Rev Bras Ginecol Obstet

97. CAMPOS CS, Bovo AC, Fonseca B, Santana IV, et al
    Performance of HPV testing and liquid-based cytology after negative colposcopy in women with ASC-H, HSIL or AGC cytology.
    Rev Bras Ginecol Obstet. 2026;48:e-rbgo62.
    PubMed         Abstract available
    
    

    
    Surg Pathol Clin

98. DEVINS KM
    Rhabdomyosarcoma of the Cervix/Vagina and Its Mimics.
    Surg Pathol Clin. 2026;19:637-646.
    PubMed         Abstract available
    
    
99. HODGSON A, Park KJ
    An Atlas-Based Approach to Assigning International Federation of Gynecology and Obstetrics Stage to Different Presentations of Cervical Cancer.
    Surg Pathol Clin. 2026;19:553-567.
    PubMed         Abstract available
    
    

    
    Taiwan J Obstet Gynecol

100. YANG ST, Wang PH
     Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events.
     Taiwan J Obstet Gynecol. 2026;65:1080-1082.
     PubMed        
     
     
101. WANG PH, Morisada T, Kobayashi Y, Tjokroprawiro BA, et al
     The positive association between radiotherapy and subsequent ischemia stroke in the cervical cancer patients is worthy of attention.
     Taiwan J Obstet Gynecol. 2026;65:1070-1072.
     PubMed        
     
     

     
     Virchows Arch

102. ARORA I, Ganesan R, Sokhi T, Shiomi T, et al
     Cervical HPV-independent adenosquamous carcinoma: report of a case series.
     Virchows Arch. 2026;489:963-972.
     PubMed         Abstract available
     
     

     
     Virus Res

103. TIPPAYAWONG R, Kansandee W, Loymunkong C, Sirinantananon P, et al
     Corrigendum to "In vitro and in silico antiviral activity of Polyscias scutellaria leaf extract against drug-susceptible and drug-resistant herpes simplex virus and human papillomavirus-positive cervical cancer: implications for topical formulation de
     Virus Res. 2026 Oct 27:199819. doi: 10.1016/j.virusres.2026.199819.
     PubMed        
     
     

     
     Zhong Nan Da Xue Xue Bao Yi Xue Ban

104. CHEN Y, Jiang Y, Wang Q, He Z, et al
     RBM15/IGF2BP1-mediated m(6)A methylation of AKR1B10 promotes the progression of cervical squamous cell carcinoma.
     Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026;51:1661-1676.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum